Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following drugs is NOT metabolized by acetylation?

Metoclopramide. ***Metoclopramide*** - **Metoclopramide** is eliminated primarily via renal excretion, with a smaller portion undergoing glucuronidation and sulfation, not acetylation. - Its metabolic pathway does not involve the enzyme **N-acetyltransferase**, which is responsible for acetylation. *Dapsone* - **Dapsone** undergoes significant **N-acetylation** by NAT2 (N-acetyltransferase 2), which is important for its metabolism and clearance. - Genetic variations in NAT2 can lead to individual differences in **dapsone acetylation rates**, affecting drug efficacy and toxicity. *Procainamide* - **Procainamide** is primarily metabolized by N-acetyltransferase 2 (NAT2) to **N-acetylprocainamide (NAPA)**, an active metabolite. - Differences in **acetylation phenotype** (slow vs. rapid acetylators) influence the metabolism of procainamide and the risk of drug-induced lupus. *INH* - **Isoniazid (INH)** is extensively metabolized in the liver, primarily by **N-acetylation** via the enzyme N-acetyltransferase 2 (NAT2). - The rate of INH acetylation varies significantly among individuals, classifying them as **slow or rapid acetylators**, which impacts drug toxicity and efficacy.

Q: Which of the following statements represents the most clinically significant aspect of drug metabolism?

Most common enzyme involved is CYP 3A4/5. ***Most common enzyme involved is Cyp 3A4/5*** - CYP3A4/5 is the **most abundant and clinically significant** cytochrome P450 enzyme, responsible for metabolizing approximately **50% of all clinically used drugs**. - Its widespread involvement means variations in its activity (due to **genetics, drug interactions, or disease**) have a major impact on drug efficacy and toxicity. *Glucuronidation is a phase II reaction* - While correct that glucuronidation is a **Phase II metabolic reaction**, this statement describes a biochemical classification rather than a clinically significant aspect compared to the involvement of CYP3A4/5. - Phase II reactions generally involve **conjugation** to increase water solubility and facilitate excretion, but they do not collectively account for as many drug interactions as CYP3A4/5 alone. *Reduction is a phase I reaction* - This statement is factually correct as **reduction** is indeed a **Phase I metabolic reaction**. - However, it represents a generic classification of a metabolic pathway and doesn't highlight the specific clinical importance or prevalence of a particular enzyme or reaction in drug metabolism. *Cytochrome P450 is involved in phase I reactions* - This is true; the **cytochrome P450 system** is the primary enzyme system for **Phase I metabolism**, which introduces or exposes polar groups to make drugs more reactive. - While fundamentally important, this statement is too broad; it does not specify the most clinically significant *aspect* or *enzyme* within the P450 system compared to directly identifying CYP3A4/5.

Q: Which of the following pairs are considered physiological antagonists in pharmacology?

Histamine and Adrenaline. ***Histamine and Adrenaline*** - **Physiological antagonism** occurs when two drugs produce opposite effects by acting on different receptors or pathways. - **Histamine** causes bronchoconstriction and vasodilation, while **adrenaline** causes bronchodilation and vasoconstriction, counteracting each other's effects through different mechanisms. *Adrenaline and Isoprenaline* - Both **adrenaline** and **isoprenaline** are **adrenergic agonists** that produce similar physiological effects, primarily through beta-adrenergic receptor activation. - They are not physiological antagonists but rather have **synergistic** or similar pharmacological actions. *Isoprenaline and Propranolol* - **Isoprenaline** is a **beta-adrenergic agonist**, while **propranolol** is a **beta-adrenergic antagonist**. - This is an example of **pharmacological antagonism (receptor antagonism)**, where one drug blocks the effect of another at the same receptor site, rather than physiological antagonism.

Q: Which of the following drug combinations demonstrates receptor level antagonism?

Isoprenaline (agonist) and Propranolol (antagonist). ***Isoprenaline (agonist) and Propranolol (antagonist)*** - **Propranolol** is a **beta-adrenergic receptor antagonist**, meaning it binds to and blocks beta-adrenergic receptors. - **Isoprenaline** is a **beta-adrenergic receptor agonist**, meaning it activates these same receptors. Their combined action demonstrates **receptor-level antagonism** as propranolol prevents isoprenaline from binding and eliciting its effect. *Histamine and Adrenaline* - This combination illustrates **physiological antagonism**, where two drugs produce opposite effects through different mechanisms and different receptors. - **Adrenaline** causes bronchodilation and vasoconstriction via adrenergic receptors, counteracting the effects of **histamine** (e.g., bronchoconstriction, vasodilation) which acts on histamine receptors. *Adrenaline and Isoprenaline* - Both **adrenaline** and **isoprenaline** are **agonists** of adrenergic receptors, specifically beta-adrenergic receptors. - They would produce similar effects (e.g., increased heart rate, bronchodilation) rather than opposing each other at the receptor level. *None of the options* - This is incorrect because **Isoprenaline and Propranolol** is a valid example of receptor-level antagonism, making this option unnecessary.

Q: Among the following statins, which has the longest half-life?

Rosuvastatin. **Rosuvastatin** - **Rosuvastatin** has the longest half-life among the commonly used statins, approximately **19 hours**, allowing for consistent lipid-lowering effects. - Its prolonged presence in the body contributes to its effectiveness in reducing **LDL-C** at lower doses. *Pravastatin* - **Pravastatin** has a relatively short half-life of about **1.8 hours**, requiring daily dosing to maintain therapeutic concentrations. - Its hydrophilic nature means it is less likely to penetrate non-hepatic tissues, potentially reducing extrahepatic side effects. *Simvastatin* - **Simvastatin** has a short half-life of about **3 hours**, necessitating daily administration. - It is a **prodrug** that requires hepatic activation to its active beta-hydroxy acid form. *Lovastatin* - **Lovastatin** also has a short half-life, around **3 hours**, and is a **prodrug** like simvastatin. - It is often recommended to be taken in the evening due to the diurnal rhythm of cholesterol synthesis.

Q: Which second generation antihistaminic does not produce an active metabolite?

Cetirizine. ***Cetirizine*** - Cetirizine is unique among second-generation antihistamines as it is an **active metabolite** of hydroxyzine and **does not undergo further significant metabolism** to an active compound. - This characteristic contributes to its relatively **predictable pharmacokinetics** and reduced potential for drug interactions related to metabolism. *Loratadine* - Loratadine is a **prodrug** that is extensively metabolized in the liver by **CYP3A4 and CYP2D6** to its active metabolite, **desloratadine**. - Desloratadine is responsible for most of the **antihistaminic effects** of loratadine. *Terfenadine* - Terfenadine is a **prodrug** that is extensively metabolized by **CYP3A4** to its active metabolite, **fexofenadine**. - Due to its **cardiotoxicity** (QT prolongation) when its metabolism was inhibited, terfenadine was withdrawn from the market, and fexofenadine was developed as a safer alternative. *None of the options* - This option is incorrect because **cetirizine** does not produce an active metabolite, making it a valid answer for the question.

Q: Which of the following is a metabolite of hydroxyzine?

Cetirizine. ***Cetirizine*** - **Cetirizine** is the principal active metabolite of **hydroxyzine**, formed through the oxidation of the primary alcohol group of hydroxyzine [2]. - Both hydroxyzine and cetirizine are **H1-receptor antagonists**, but cetirizine is a **second-generation antihistamine** known for being less sedating due to its limited ability to cross the blood-brain barrier [2]. *Fexofenadine* - **Fexofenadine** is an active metabolite of **terfenadine**, not hydroxyzine [2]. - **Fexofenadine** is a second-generation antihistamine used to treat allergies, known for its non-sedating properties [3]. *Terfenadine* - **Terfenadine** is a second-generation antihistamine that was withdrawn from the market due to its cardiotoxicity, particularly the risk of **QT prolongation** and **Torsades de Pointes**. - Its active metabolite is **fexofenadine**, which does not cause similar cardiac issues [2]. *Azelastine* - **Azelastine** is an antihistamine primarily available as a **nasal spray** for the treatment of allergic rhinitis and conjunctivitis [1], [3]. - It is not a metabolite of hydroxyzine but a distinct therapeutic compound.

Q: In the context of pharmacology, which plasma protein do acidic drugs primarily bind to?

Albumin. ***Albumin*** - **Albumin** is the most abundant plasma protein and has multiple binding sites for a wide range of drugs, particularly **acidic drugs**. - Its high concentration and diverse binding capabilities make it the primary transporter for many **lipophilic** and **anionic drugs**. *Globulin* - **Globulins** are a diverse group of proteins, some of which bind to drugs, but they primarily transport **hormones**, **metals**, and **vitamins**, not acidic drugs. - They are less significant for binding acidic drugs compared to albumin. *α1-acid glycoprotein* - **α1-acid glycoprotein** primarily binds to **basic drugs** due to its numerous acidic residues. - While it plays a crucial role in binding basic compounds, it has limited affinity for acidic drugs. *None of the options* - This option is incorrect because **albumin** is a well-established and significant plasma protein for binding acidic drugs. - Specific plasma proteins are known to bind different types of drugs, and for acidic drugs, albumin is the primary binder.

Q: Which drug has the highest plasma protein binding?

Warfarin. ***Warfarin*** - **Warfarin** exhibits very **high plasma protein binding**, typically greater than 99%, primarily to albumin. - This high binding capacity means that only a small fraction of the drug is free and pharmacologically active. - Due to high protein binding, warfarin is susceptible to drug interactions when displaced from albumin. *Verapamil* - **Verapamil** has a relatively high plasma protein binding, around 90%, but it is not as high as warfarin. - Its binding is predominantly to **albumin** and alpha-1-acid glycoprotein. *Aspirin* - **Aspirin** (acetylsalicylic acid) has moderate plasma protein binding, usually between 50-90%, depending on the dosage. - It binds to **albumin** and can displace other protein-bound drugs. *GTN* - **Glyceryl trinitrate (GTN)** has moderate plasma protein binding, approximately 60%. - Its rapid onset and short duration of action are primarily due to its extensive first-pass metabolism and quick redistribution, rather than protein binding characteristics.

Question 1

Which statement best describes first-order kinetics in pharmacokinetics?

Accepted Answer

Elimination of the drug is proportional to the serum concentration

Answer

Absorption of the drug is independent of the serum concentration

Answer

Absorption of the drug is proportional to the serum concentration

Answer

Elimination of the drug is independent of the serum concentration

Question 2

Which of the following drugs is NOT metabolized by acetylation?

Accepted Answer

Metoclopramide

Answer

Dapsone

Answer

Procainamide

Answer

INH

Question 3

Which of the following statements represents the most clinically significant aspect of drug metabolism?

Accepted Answer

Most common enzyme involved is CYP 3A4/5

Answer

Glucuronidation is a phase II reaction

Answer

Reduction is a phase I reaction

Answer

Cytochrome P450 is involved in phase I reactions

Question 4

Which of the following pairs are considered physiological antagonists in pharmacology?

Accepted Answer

Histamine and Adrenaline

Answer

Adrenaline and Isoprenaline

Answer

Isoprenaline and Propranolol

Answer

All of the options

Question 5

Which of the following drug combinations demonstrates receptor level antagonism?

Accepted Answer

Isoprenaline (agonist) and Propranolol (antagonist)

Answer

Histamine and Adrenaline

Answer

Adrenaline and Isoprenaline

Answer

None of the options

Question 6

Among the following statins, which has the longest half-life?

Accepted Answer

Rosuvastatin

Answer

Pravastatin

Answer

Simvastatin

Answer

Lovastatin

Question 7

Which second generation antihistaminic does not produce an active metabolite?

Accepted Answer

Cetirizine

Answer

Loratadine

Answer

Terfenadine

Answer

None of the options

Question 8

Which of the following is a metabolite of hydroxyzine?

Accepted Answer

Cetirizine

Answer

Fexofenadine

Answer

Terfenadine

Answer

Azelastine

Question 9

In the context of pharmacology, which plasma protein do acidic drugs primarily bind to?

Accepted Answer

Albumin

Answer

Globulin

Answer

α1-acid glycoprotein

Answer

None of the options

Question 10

Which drug has the highest plasma protein binding?

Accepted Answer

Warfarin

Answer

Verapamil

Answer

Aspirin

Answer

GTN

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?